Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3205)
All Articles published online
|
Mar 1, 2004 (publication date) through Apr 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jeng KS, Sheen IS, Wang YC, Gu SL, Chu CM, Shih SC, Wang PC, Chang WH, Wang HY. Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection ? World J Gastroenterol 2004; 10(5): 676-681 [PMID: 14991937 DOI: 10.3748/wjg.v10.i5.676] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i5/676.htm |
| Number | Citing Articles |
| 1 |
Masayuki Kanematsu, Richard C Semelka, Shinji Osada, Nozomi Amaoka. Magnetic Resonance Imaging and Expression of Vascular Endothelial Growth Factor in Hepatocellular Nodules in Cirrhosis and Hepatocellular Carcinomas. Topics in Magnetic Resonance Imaging 2005; 16(1): 67 doi: 10.1097/01.rmr.0000191133.91603.d2
|
| 2 |
Ming‐Yen Hsieh, Zu‐Yau Lin, Wan‐Long Chuang. Serial serum VEGF‐A, angiopoietin‐2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization. The Kaohsiung Journal of Medical Sciences 2011; 27(8): 314 doi: 10.1016/j.kjms.2011.03.008
|
| 3 |
Melanie B. Thomas, Jeffrey S. Morris, Romil Chadha, Michiko Iwasaki, Harmeet Kaur, Elinor Lin, Ahmed Kaseb, Katrina Glover, Marta Davila, James Abbruzzese. Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma. Journal of Clinical Oncology 2009; 27(6): 843 doi: 10.1200/JCO.2008.18.3301
|
| 4 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
| 5 |
Xia Zhang, Zhixian Wu, Yonghai Peng, Dongliang Li, Yi Jiang, Fan Pan, Yi Li, Yanhua Lai, Zhongyuan Cui, Kun Zhang, Junyan Tao. Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/6651397
|
| 6 |
Hyun Young Woo, So Young Yoo, Jeong Heo. Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma. Molecules 2021; 26(2): 295 doi: 10.3390/molecules26020295
|
| 7 |
Andrew X. Zhu, Dan G. Duda, Dushyant V. Sahani, Rakesh K. Jain. HCC and angiogenesis: possible targets and future directions. Nature Reviews Clinical Oncology 2011; 8(5): 292 doi: 10.1038/nrclinonc.2011.30
|
| 8 |
M. Kanematsu, S. Osada, N. Amaoka, S. Goshima, H. Kondo, N. Moriyama. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT. Abdominal Imaging 2006; 31(1): 78 doi: 10.1007/s00261-005-0091-4
|
| 9 |
Satoshi Miuma, Tatsuki Ichikawa, Kazuhiko Arima, Shigeyuki Takeshita, Toru Muraoka, Toshihisa Matsuzaki, Masashi Ootani, Hidetaka Shibata, Motohisa Akiyama, Eisuke Ozawa, Hisamitsu Miyaaki, Naota Taura, Fuminao Takeshima, Kazuhiko Nakao. Branched‐chain amino acid deficiency stabilizes insulin‐induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells. Journal of Cellular Biochemistry 2012; 113(10): 3113 doi: 10.1002/jcb.24188
|
| 10 |
Roberta Pang, Ronnie T.P. Poon. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 2006; 242(2): 151 doi: 10.1016/j.canlet.2006.01.008
|
| 11 |
Andrew X. Zhu, Dan G. Duda, Dushyant V. Sahani, Rakesh K. Jain. Development of Sunitinib in Hepatocellular Carcinoma: Rationale, Early Clinical Experience, and Correlative Studies. The Cancer Journal 2009; 15(4): 263 doi: 10.1097/PPO.0b013e3181af5e35
|
| 12 |
Masayuki Kanematsu, Richard C. Semelka, Shinji Osada. Liver Cancer. 2009; : 193 doi: 10.1007/978-1-4020-9804-8_14
|
| 13 |
Mikhail S. Chesnokov, Polina A. Khesina, Darya A. Shavochkina, Inna F. Kustova, Leonid M. Dyakov, Olga V. Morozova, Nikolai S. Mugue, Nikolay E. Kudashkin, Ekaterina A. Moroz, Yuri I. Patyutko, Natalia L. Lazarevich. Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma. PeerJ 2018; 6: e4915 doi: 10.7717/peerj.4915
|
| 14 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
|
| 15 |
J. Stuart Salmon, A. Craig Lockhart, Jordan Berlin. Anti-Angiogenic Treatment of Gastrointestinal Malignancies. Cancer Investigation 2005; 23(8): 712 doi: 10.1080/07357900500360024
|
| 16 |
Kinjal R. Patel, Bhairavi N. Vajaria, Rasheedunnisa Begum, Jayendra B. Patel, Franky D. Shah, Geeta M. Joshi, Prabhudas S. Patel. VEGFA isoforms play a vital role in oral cancer progression. Tumor Biology 2015; 36(8): 6321 doi: 10.1007/s13277-015-3318-1
|
| 17 |
Young Il Kim, Jin Wook Chung, Jae Hyung Park, Gyeong Hoon Kang, Minjin Lee, Kyung-Suk Suh, Kwang Gi Kim. Multiphase Contrast-Enhanced CT Imaging in Hepatocellular Carcinoma. Academic Radiology 2007; 14(9): 1084 doi: 10.1016/j.acra.2007.06.015
|
| 18 |
Vesna Gorenjak, Dwaine R. Vance, Alexandros M. Petrelis, Maria G. Stathopoulou, Sébastien Dadé, Said El Shamieh, Helena Murray, Christine Masson, John Lamont, Peter Fitzgerald, Sophie Visvikis-Siest, Rudolf Kirchmair. Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population. PLOS ONE 2019; 14(8): e0220902 doi: 10.1371/journal.pone.0220902
|
| 19 |
A. Lièvre, B. Landi, E. Mitry, J. Taïeb. Les antiangiogéniques en oncologie digestive. Gastroentérologie Clinique et Biologique 2008; 32(5): 504 doi: 10.1016/j.gcb.2008.01.042
|
| 20 |
Sean R. Rudnick, Mark W. Russo. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2018; 12(3): 265 doi: 10.1080/17474124.2018.1417035
|
| 21 |
S J Schoenleber, D M Kurtz, J A Talwalkar, L R Roberts, G J Gores. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. British Journal of Cancer 2009; 100(9): 1385 doi: 10.1038/sj.bjc.6605017
|
| 22 |
Ju Ik Moon, Jong Man Kim, Gum Oh Jung, Jae Min Chun, Gyu-Seong Choi, Jae Berm Park, Choon Hyuck David Kwon, Sung Joo Kim, Jae Won Jo. Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma. The Korean Journal of Hepatology 2008; 14(2): 185 doi: 10.3350/kjhep.2008.14.2.185
|
| 23 |
Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng. Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Critical Reviews in Oncology/Hematology 2015; 94(3): 337 doi: 10.1016/j.critrevonc.2015.01.009
|
| 24 |
Matthias Pinter, Wolfgang Sieghart, Monika Schmid, Bernhard Dauser, Gerald Prager, Hans Peter Dienes, Michael Trauner, Markus Peck‐Radosavljevic. Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF‐A expression in hepatocellular carcinoma. United European Gastroenterology Journal 2013; 1(4): 265 doi: 10.1177/2050640613496605
|
| 25 |
|